HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing ...

AccurKardia, an ECG analytics software company focused on establishing ECG as a broad biomarker, today announced a multi-year ...

AliveCor announced today that it has received CE mark in Europe for its Kardia 12L electrocardiogram (ECG) system.

Now CE Marked, the Kardia 12L ECG System leverages AI to detect 35 cardiac determinations, simplifying the ECG process and expediting access to critical heart dataMOUNTAIN VIEW, Calif., April 15, 2026 ...

Now CE Marked, the Kardia 12L ECG System leverages AI to detect 35 cardiac determinations, simplifying the ECG process and expediting access to critical heart data AliveCor's Kardia 12L launches in ...

AliveCor’s Kardia 12L, a pocket-sized AI ECG system, has received CE Mark for launch in France, Germany, Italy, Spain, and ...

HeartBeam, Inc. , a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public offering of ...

The convergence of rising neurological and cardiovascular disease prevalence, the integration of artificial intelligence into diagnostic workflows and growing demand for non-invasive monitoring ...

HeartSciences Inc.(Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the ...

ProSomnus Sleep Technologies has received the US Food and Drug Administration (FDA) Class II 510(k) clearance for its RPMO₂ OSA device.

Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining ...

Our hardware-level integration maintains authentication reliability and computational accuracy without traditional ...